Bio­Marin snags ex­pand­ed Brineu­ra la­bel, now ap­proved for all kids re­gard­less of symp­toms

The FDA has ex­pand­ed the ap­proval of Bio­Marin’s treat­ment for a ge­net­ic neu­ro­log­i­cal con­di­tion that spurs seizures and twitch­ing in young chil­dren.

The agency said …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER